Novavax says its COVID-19 vaccine gets India authorisation for children aged 12 to 17 years
Novavax announced on Tuesday (March 22) that the Drugs Controller General of India (DCGI) has granted its coronavirus (COVID-19) vaccine emergency-use authorisation for children aged 12 to 17 years. In a statement published on its website, the company noted that DCGI has granted emergency use authorisation (EUA) for Novavax jabs for adolescents. “The vaccine, also…Continue Reading